The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree.
Abstract
Initial description of apolipoprotein (apo) E-deficient transgenic mice demonstrated the development of severe hypercholesterolemia due to probable delayed clearance of large atherogenic particles from the circulation. Examination of these mice demonstrated foam cell accumulation in the aortic root and pulmonary arteries by 10 weeks of age. In the present study, the animals were fed either chow or a high-fat, Western-type diet and examined at ages ranging from 6 to 40 weeks. Gross examination by dissection microscopy revealed a predilection for development of lesions in the aortic root, at the lesser curvature of the aortic arch, the principal branches of the aorta, and in the pulmonary and carotid arteries. Monocyte attachment to endothelial cells was observed by light and electron microscopic examination at 6 weeks, the earliest time point examined. Foam cell lesions developed as early as 8 weeks, and after 15 weeks advanced lesions (fibrous plaques) were observed. The latter consisted of a fibrous cap containing smooth muscle cells surrounded by connective tissue matrix that covered a necrotic core with numerous foamy macrophages. Mice fed the Western-type diet generally had more advanced lesions than those fed a chow diet. The apoE-deficient mouse contains the entire spectrum of lesions observed during atherogenesis and is the first mouse model to develop lesions similar to those in humans. This model should provide numerous opportunities to study the pathogenesis and therapy of atherosclerosis in a small, genetically defined animal.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Apo E knockout mice are considered to be one of the most relevant models for atherosclerosis because they are hypercholesterolemic and develop spontaneous arterial lesions (87).”
From Trimethylamine N -Oxide, the Microbiome, and Heart and Kidney Disease (2017) · cites this paper as [87]
Citations
Cites
The pathogenesis of atherosclerosis: a perspective for the 1990s
Ross, R. (1993) · Nature · doi:10.1038/362801a0 · Cited by 10,618
Self-citationPlump, A. S., Smith, J. D., Hayek, T., Aalto-Setälä, K., Walsh, A., Verstuyft, J. G., Rubin, E. M., & Breslow, J. L. (1992) · Cell · doi:10.1016/0092-8674(92)90362-g · Cited by 2,263
Self-citationSpontaneous Hypercholesterolemia and Arterial Lesions in Mice Lacking Apolipoprotein E
Zhang, S. H., Reddick, R. L., Piedrahita, J. A., & Maeda, N. (1992) · Science · doi:10.1126/science.1411543 · Cited by 2,237
Rg, G. (1981) · PubMed Central · Cited by 1,314
Faggiotto, A., Ross, R., & Harker, L. A. (1984) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.4.4.323 · Cited by 978
Self-citationGown, A. M., Tsukada, T., & Ross, R. (1986) · PubMed · Cited by 678
Self-citationFaggiotto, A., & Ross, R. (1984) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.4.4.341 · Cited by 466
Self-citationThe role of the monocyte in atherogenesis: II. Migration of foam cells from atherosclerotic lesions.
Gerrity, R. G. (1981) · PubMed · Cited by 459
Severe atherosclerosis in transgenic mice expressing simian cholesteryl ester transfer protein
Marotti, K. R., Castle, C. K., Boyle, T. P., Lin, A. H., Murray, R. W., & Melchior, G. W. (1993) · Nature · doi:10.1038/364073a0 · Cited by 444
Atherosclerosis in Transgenic Mice Overexpressing Apolipoprotein A-II
Warden, C. H., Hedrick, C. C., Qiao, J.-H., Castellani, L. W., & Lusis, A. J. (1993) · Science · doi:10.1126/science.8332912 · Cited by 359
Cited by
Sorted by citations
Items 701–800 of 1,000
Merino, V. F., Todiraş, M., Mori, M. A., Sales, V., Fonseca, R. G., Saul, V., Tenner, K., Bäder, M., & Pesquero, J. B. (2009) · Journal of Molecular Medicine · doi:10.1007/s00109-009-0501-0 · Cited by 40
Spontaneously hyperlipidemic (SHL) mice: Japanese wild mice with apolipoprotein E deficiency
Matsushima, Y., Hayashi, S., & Tachibana, M. (1999) · Mammalian Genome · doi:10.1007/s003359901000 · Cited by 40
Impairment of Endothelium-Dependent Arterial Relaxation By High-Fat Feeding in ApoE-Deficient Mice
Deckert, V., Lizard, G., Duverger, N., Athias, A., Palleau, V., Emmanuel, F., Moisant, M., Gambert, P., Lallemant, C., & Lagrost, L. (1999) · Circulation · doi:10.1161/01.cir.100.11.1230 · Cited by 40
Cristofori, P. G., Lanzoni, A., Quartaroli, M., Pastorino, A. M., Zancanaro, C., Cominacini, L., Gaviraghi, G., & Turton, J. A. (2000) · Journal of Hypertension · doi:10.1097/00004872-200018100-00010 · Cited by 40
Harris, J. D. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.1.43 · Cited by 41
Finkelstein, J. M., Heemels, M.-T., Shadan, S., & Weiss, U. K. (2014) · Nature · doi:10.1038/510047a · Cited by 41
Gallic, C. L., Phalente, Y., Manens, L., Dublineau, I., Benderitter, M., Guéguen, Y., Lehoux, S., & Ebrahimian, T. G. (2015) · PLoS ONE · doi:10.1371/journal.pone.0128539 · Cited by 39
Lénárt, N., Walter, F. R., Bocsik, A., Sántha, P., Tóth, M. E., Harazin, A., Tóth, A. E., Vízler, C., Török, Z., Pilbat, A., et al. (2015) · Fluids and Barriers of the CNS · doi:10.1186/s12987-015-0013-y · Cited by 41
Nox enzymes and oxidative stress in atherosclerosis
Simionescu, M. (2012) · Frontiers in Bioscience-Scholar · doi:10.2741/s291 · Cited by 39
Catanzaro, D. F., Zhou, Y. Y., Chen, R., Yu, F., Catanzaro, S., Lorenzo, M. S. D., Subbaramaiah, K., Zhou, X. K., Praticò, D., Dannenberg, A. J., et al. (2007) · Cardiovascular Toxicology · doi:10.1007/s12012-007-0027-z · Cited by 39
Zetterqvist, A. V., Berglund, L. M., Blanco, F., Garcia‐Vaz, E., Wigren, M., Dunér, P., Andersson, A. D., To, F., Spégel, P., Nilsson, J. Å., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065020 · Cited by 39
Kramer, C. D., Simas, A. M., He, X., Ingalls, R. R., Weinberg, E. O., & Genco, C. A. (2017) · Anaerobe · doi:10.1016/j.anaerobe.2017.04.011 · Cited by 39
Casós, K., Sáiz, M. P., Ruiz-Sanz, J. I., & Mitjavila, M. T. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.02.033 · Cited by 39
Rezzani, R., Favero, G., Stacchiotti, A., & Rodella, L. F. (2012) · Life Sciences · doi:10.1016/j.lfs.2012.11.011 · Cited by 39
Ketonen, J., Merasto, S., Paakkari, I., & Mervaala, E. M. A. (2005) · Blood Pressure · doi:10.1080/08037050500383687 · Cited by 39
Endothelin, hypercholesterolemia and atherosclerosis
Barton, M., Traupe, T., & Haudenschild, C. C. (2003) · Coronary Artery Disease · doi:10.1097/00019501-200311000-00002 · Cited by 39
Spontaneous Atherothrombosis and Medial Degradation in Apoe −/− , Npc1 −/− Mice
Welch, C. L., Sun, Y., Arey, B. J., Lemaitre, V., Sharma, N., Ishibashi, M., Sayers, S., Li, R., Gorelik, A., Pleskac, N., et al. (2007) · Circulation · doi:10.1161/circulationaha.107.701276 · Cited by 39
Shi, C., Lee, W., Russell, M. E., Zhang, D., Fletcher, D. L., Newell, J. B., & Haber, E. (1997) · Circulation · doi:10.1161/01.cir.96.8.2722 · Cited by 39
Jiang, J., Valen, G., Tokuno, S., Thorén, P., & Pernow, J. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703705 · Cited by 39
Fetterman, J. L., Pompilius, M., Westbrook, D. G., Uyeminami, D. L., Brown, J. A., Pinkerton, K. E., & Ballinger, S. W. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066835 · Cited by 38
The Downstream Regulation of Chemokine Receptor Signalling: Implications for Atherosclerosis
Patel, J., Channon, K. M., & McNeill, E. (2013) · Mediators of Inflammation · doi:10.1155/2013/459520 · Cited by 41
Beilvert, A., Cormode, D. P., Chaubet, F., Briley-Saebo, K. C., Mani, V., Mulder, W. J. M., Vucic, E., Toussaint, J., Letourneur, D., & Fayad, Z. A. (2009) · Magnetic Resonance in Medicine · doi:10.1002/mrm.22103 · Cited by 38
Deosarkar, S. P., Malgor, R., Fu, J., Kohn, L. D., Hanes, J. S., & Goetz, D. J. (2008) · Biotechnology and Bioengineering · doi:10.1002/bit.21885 · Cited by 38
A major role for RCAN1 in atherosclerosis progression
Méndez‐Barbero, N., Esteban, V., Villahoz, S., Escolano, A., Urso, K., Alfranca, A., Rodrı́guez, C., Sánchez, S. A., Osawa, T., Andrés, V., et al. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201302842 · Cited by 38
Wang, D., Wang, W., Lin, W., Yang, W., Zhang, P., Chen, M., Ding, D., Liu, C., Zheng, J., & Ling, W. (2018) · Cardiovascular Research · doi:10.1093/cvr/cvy132 · Cited by 38
Stigmasterol accumulation causes cardiac injury and promotes mortality
Tao, C., Shkumatov, A. A., Alexander, S. T., Ason, B. L., & Zhou, M. (2019) · Communications Biology · doi:10.1038/s42003-018-0245-x · Cited by 38
Singh, N. K., Kotla, S., Dyukova, E., Traylor, J. G., Orr, A. W., Chernoff, J., Marion, T. N., & Rao, G. N. (2015) · Nature Communications · doi:10.1038/ncomms8450 · Cited by 38
Koo, H. J., Park, H. J., Byeon, H.-E., Kwak, J. H., Um, S. H., Kwon, S. T., Rhee, D. K., & Pyo, S. (2014) · Journal of Food Science · doi:10.1111/1750-3841.12401 · Cited by 39
Ekstrand, M., Trajkovska, M., Perman, J., Fogelstrand, P., Adiels, M., Johansson, M., Hultén, L. M., Borén, J., & Levin, M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0130898 · Cited by 38
Clinical significance of macrophage phenotypes in cardiovascular disease
Medbury, H. J., Williams, H., & Fletcher, J. (2014) · Clinical and Translational Medicine · doi:10.1186/s40169-014-0042-1 · Cited by 39
Rong, J. X., Blachford, C., Feig, J. E., Bander, I., Mayne, J., Kusunoki, J., Miller, C., Davis, M., Wilson, M. D., Dehn, S., et al. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.252056 · Cited by 38
Wei, J., Zheng, M., Liang, P., Wei, Y., Yin, X., Tang, Y., & Xue, Y. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.04.009 · Cited by 38
Erectile Dysfunction in Hypercholesterolemic Atherosclerotic Apolipoprotein E Knockout Mice
Behr‐Roussel, D., Darblade, B., Oudot, A., Compagnie, S., Bernabé, J., Alexandre, L., & Giuliano, F. (2006) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2006.00282.x · Cited by 38
Imaging of Aortic Atherosclerotic Lesions by 125I-LDL, 125I-Oxidized-LDL, 125I-HDL and 125I-BSA
Shaish, A., Keren, G., Chouraqui, P., Levkovitz, H., & Harats, D. (2001) · Pathobiology · doi:10.1159/000055947 · Cited by 38
PPARs in atherosclerosis: The spatial and temporal features from mechanism to druggable targets
Zheng, Y., Shao, M., Zheng, Y., Sun, W., Qin, S., Sun, Z., Zhu, L., Guan, Y., Wang, Q., Wang, Y., et al. (2024) · Journal of Advanced Research · doi:10.1016/j.jare.2024.03.020 · Cited by 41
Fintel, D. J. (2012) · Vascular Health and Risk Management · doi:10.2147/vhrm.s26030 · Cited by 40
Modelling the Impact of Atherosclerosis on Drug Release and Distribution from Coronary Stents
McKittrick, C. M., Kennedy, S., Oldroyd, K. G., McGinty, S., & McCormick, C. (2015) · Annals of Biomedical Engineering · doi:10.1007/s10439-015-1456-7 · Cited by 37
Molecular Imaging of Vulnerable Atherosclerotic Plaques in Animal Models
Gargiulo, S., Gramanzini, M., & Mancini, M. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17091511 · Cited by 38
Atherosclerosis proceeds independently of thrombin-induced platelet activation in ApoE−/− mice
Hamilton, J. R., Cornelissen, I., Mountford, J. K., & Coughlin, S. R. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.01.018 · Cited by 37
Yu, P., Xiong, T., Tenedero, C. B., Lebeau, P. F., Ni, R., MacDonald, M. E., Gross, P. L., Austin, R. C., & Trigatti, B. L. (2017) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.117.305140 · Cited by 37
Endothelin-1 (1–31): From chymase-dependent synthesis to cardiovascular pathologies
D’Orléans-Juste, P., Houde, M., Rae, G. A., Bkaily, G., Carrier, É., & Simard, É. (2008) · Vascular Pharmacology · doi:10.1016/j.vph.2008.06.007 · Cited by 37
Han, H., Yan, P., Chen, L., Luo, C., Gao, H. Y., Deng, Q., Zheng, M., Shi, Y., & Liu, L. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/958217 · Cited by 37
Regulation of Atherosclerosis and Associated Risk Factors by Adenosine and Adenosine Receptors
Koupenova, M., Johnston‐Cox, H., & Ravid, K. (2012) · Current Atherosclerosis Reports · doi:10.1007/s11883-012-0263-y · Cited by 37
CCL19 and CCL21 modulate the inflammatory milieu in atherosclerotic lesions
Akhavanpoor, M., Gleissner, C. A., Gorbatsch, S., Doesch, A. O., Akhavanpoor, H., Wangler, S., Jahn, F., Lasitschka, F., Katus, H. A., & Erbel, C. (2014) · Drug Design Development and Therapy · doi:10.2147/dddt.s72394 · Cited by 39
Chen, Y., Huang, W., Yang, M., Xin, G., Cui, W., Xie, Z., & Silverstein, R. L. (2017) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.117.309444 · Cited by 37
Dang, V. T., Zhong, L. H., Huang, A., Deng, A., & Werstuck, G. H. (2018) · Metabolomics · doi:10.1007/s11306-018-1392-2 · Cited by 36
Vinué, Á., Herrero-Cervera, A., & Navarro, H. G. (2018) · Nutrients · doi:10.3390/nu10070939 · Cited by 37
AAV8-mediated overexpression of mPCSK9 in liver differs between male and female mice
Vozenilek, A. E., Blackburn, C. M. R., Schilke, R. M., Chandran, S., Castore, R., Klein, R. L., & Woolard, M. D. (2018) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2018.09.005 · Cited by 36
Oh, S., Son, M., Park, C. H., Jang, J. T., Son, K. H., & Byun, K. (2020) · Marine Drugs · doi:10.3390/md18120648 · Cited by 35
Shear stress control of vascular leaks and atheromas through Tie2 activation by VE‐PTP sequestration
Shirakura, K., Bałuk, P., Nottebaum, A. F., Ipe, U., Peters, K. G., McDonald, D. M., & Vestweber, D. (2023) · EMBO Molecular Medicine · doi:10.15252/emmm.202216128 · Cited by 36
Liuba, P., Pesonen, E. J., Paakkari, I., Batra, S. C., Andersen, L. P., Forslid, A., Ylä‐Herttuala, S., Persson, K., Wadström, T., Wang, X., et al. (2003) · Journal of Vascular Research · doi:10.1159/000070708 · Cited by 36
Collins, M. J., Bersi, M. R., Wilson, E., & Humphrey, J. D. (2011) · Medical Engineering & Physics · doi:10.1016/j.medengphy.2011.06.003 · Cited by 36
Zhou, F., Pan, Y., Huang, Z., Jia, Y., Zhao, X., Chen, Y., Diao, J., Wan, Q., & Cui, X. (2013) · Cell Stress and Chaperones · doi:10.1007/s12192-013-0417-z · Cited by 36
Ni, W., Tsuda, Y., Takashima, S., Sato, H., Sato, M., & Imaizumi, K. (2003) · British Journal Of Nutrition · doi:10.1079/bjn2003878 · Cited by 36
Mangiapane, E. H., McAteer, M. A., Benson, G. M., White, D. A., & Salter, A. M. (1999) · British Journal Of Nutrition · doi:10.1017/s0007114599001646 · Cited by 36
New insights into atherosclerosis from studies with mouse models
Shih, D. M., Welch, C. L., & Lusis, A. J. (1995) · Molecular Medicine Today · doi:10.1016/s1357-4310(95)93834-6 · Cited by 36
Neužil, J., Christison, J. K., Iheanacho, E. N., Fragonas, J., Zammit, V. C., Hunt, N. H., & Stocker, R. (1998) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33897-9 · Cited by 36
Bentzon, J. F., Pasterkamp, G., & Falk, E. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000051387.70962.79 · Cited by 36
Mouse Models of Atherosclerosis
Maganto-García, E., Tarrio, M. L., & Lichtman, A. H. (2012) · Current Protocols in Immunology · doi:10.1002/0471142735.im1524s96 · Cited by 35
Diet and Atherosclerosis in Apolipoprotein E-Deficient Mice
Imaizumi, K. (2011) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.110059 · Cited by 35
Jing, L., Parker, C. E., Seo, D., Hines, M. W., Dicheva, N. N., Yu, Y., Schwinn, D. A., Ginsburg, G. S., & Chen, X. (2011) · PROTEOMICS · doi:10.1002/pmic.201000202 · Cited by 35
Catanozi, S., Rocha, J. C., Passarelli, M., Guzzo, M. L., Alves, C., Furukawa, L. N. S., Nunes, V. S., Nakandakare, E. R., Heimann, J. C., & Quintão, E. C. R. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m200330-jlr200 · Cited by 35
Use of Mouse Models in Atherosclerosis Research
Getz, G. S., & Reardon, C. A. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2929-0_1 · Cited by 38
CD301b/MGL2 + Mononuclear Phagocytes Orchestrate Autoimmune Cardiac Valve Inflammation and Fibrosis
Meier, L. A., Auger, J. L., Engelson, B. J., Cowan, H. M., Breed, E. R., González‐Torres, M. I., Boyer, J. D., Verma, M., Marath, A., & Binstadt, B. A. (2018) · Circulation · doi:10.1161/circulationaha.117.033144 · Cited by 36
The potential for novel anti-inflammatory therapies for coronary artery disease
Cascieri, M. A. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd723 · Cited by 35
Fluvastatin Prevents Renal Dysfunction and Vascular NO Deficit in Apolipoprotein E-Deficient Mice
Gervais, M., Pons, S., Nicoletti, A., Cosson, C., Giudicelli, J., & Richer, C. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000051404.84665.49 · Cited by 35
Qiao, Y., Zhang, P., Lu, X., Sun, W., Liu, G.-L., Ren, M., Lei, Y., & Zhang, J. (2014) · Chinese Journal of Integrative Medicine · doi:10.1007/s11655-014-1832-4 · Cited by 34
Wing, L.-Y. C., Chen, Y.-C., Shih, Y., Cheng, J., Lin, Y., & Jiang, M. J. (2009) · Experimental Biology and Medicine · doi:10.3181/0811-rm-332 · Cited by 35
Yoon, J. J., Lee, Y. J., Han, B. H., Choi, E. S., Kho, M. C., Park, J. H., Ahn, Y. M., Kim, H. Y., Kang, D. G., & Lee, H. S. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.11.044 · Cited by 34
Zhang, R., Han, S., Zhang, Z., Zhang, W., Yang, J., Wan, Z., & Qin, L. (2018) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.8b00380 · Cited by 34
Augstein, A., Mierke, J., Poitz, D. M., & Strasser, R. H. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.05.009 · Cited by 34
Jiang, L., Hao, C.-J., Li, Z., Zhang, P., Wang, S., Yang, S., Wei, F., & Zhang, J. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.11.114 · Cited by 34
Chen, T., Luo, W., Wu, G., Wu, L., Huang, S., Li, J., Wang, J., Hu, X., Huang, W., & Liang, G. (2019) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2019.03.012 · Cited by 35
Zhen, Z., Ren, S., Ji, H., Ding, X., Zou, P., & Lu, J. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.06.113 · Cited by 34
Siglec-E retards atherosclerosis by inhibiting CD36-mediated foam cell formation
Hsu, Y., Hsu, F., Chiang, M., Tsai, D.-L., Li, F., Angata, T., Crocker, P. R., & Chau, L. (2021) · Journal of Biomedical Science · doi:10.1186/s12929-020-00698-z · Cited by 35
Santos‐Sánchez, G., Cruz‐Chamorro, I., Álvarez‐Ríos, A. I., Álvarez‐Sánchez, N., Rodríguez-Ortiz, B., Álvarez‐López, A. I., Fernández‐Pachón, M., Pedroche, J., Millán, F., Millán-Linares, M. C., et al. (2022) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.2c00809 · Cited by 35
Mikael, L. G., Wang, X., Wu, Q. H., Jiang, H., Maclean, K. N., & Rozen, R. R. (2009) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2009.05.011 · Cited by 34
Estrogen improves vascular function via peroxisome-proliferator-activated-receptor-γ
Tiyerili, V., Müller, C., Fung, S., Panek, D., Nickenig, G., & Becher, U. M. (2012) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2012.05.008 · Cited by 34
Lipoproteins and Cellular Cholesterol Homeostasis
Johnson, W. J., Phillips, M. C., & Rothblat, G. H. (1997) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-1-4615-5901-6_9 · Cited by 33
Grimsditch, D. C., Penfold, S., Latcham, J., Vidgeon-Hart, M., Groot, P. H. E., & Benson, G. M. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00400-1 · Cited by 34
Ferré, N., Camps, J., Paul, A., Cabré, M., Calleja, L., Osada, J., & Joven, J. (2001) · Molecular and Cellular Biochemistry · doi:10.1023/a:1007296919243 · Cited by 34
Young, S., Veniant, M., Beigneux, A., Bensadoun, A., & Fong, L. (2008) · Current Drug Targets · doi:10.2174/138945008783755629 · Cited by 33
Yang, X., Yu, H., Fu, J., Guo, H., Han, P., Ma, S., Pan, L., Zhang, Z., Xu, H., Hu, J.-C., et al. (2022) · Theranostics · doi:10.7150/thno.76805 · Cited by 33
Endothelial Dysfunction in Atherosclerosis: Experimental Models and Therapeutics
Kopych, V., Costa, A. D. S. D., & Park, K. (2025) · Biomaterials Research · doi:10.34133/bmr.0252 · Cited by 33
Erdely, A., Kepka‐Lenhart, D., Salmen‐Muniz, R., Chapman, R. S., Hulderman, T., Kashon, M. L., Simeonova, P. P., & Morris, S. M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015253 · Cited by 34
Cai, Y., Xie, K., Fan, Z., & Liu, S. (2018) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-018-9828-7 · Cited by 33
Trusca, V. G., Fuior, E. V., Florea, I. C., Kardassis, D., Simionescu, M., & Gafencu, A. V. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.179572 · Cited by 33
Assémat, P., Siu, K. K. W., Armitage, J. A., Hokke, S., Dart, A. M., Chin-Dusting, J. P. F., & Hourigan, K. (2014) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2014.07.004 · Cited by 33
Zhang, J., Hou, Y.-L., Lu, W., Ni, X.-Q., Lin, F., Yu, Y.-R., Tang, C., & Qi, Y. (2016) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.34082 · Cited by 33
Eue, I., Langer, C., von Eckardstein, A., & Sorg, C. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(00)00476-7 · Cited by 33
Schneider, J. E., McAteer, M. A., Tyler, D. J., Clarke, K. J., Channon, K. M., Choudhury, R. P., & Neubauer, S. (2004) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.20211 · Cited by 33
Mouse models of atherosclerosis.
Smith, J. D. (1998) · PubMed · Cited by 33
Cerebral lipid deposition in aged apolipoprotein-E-deficient mice.
Walker, L. C., Parker, C. A., Lipinski, W. J., Callahan, M. J., Carroll, R. T., Gandy, S., Smith, J. D., Jucker, M., & Bisgaier, C. L. (1997) · Europe PMC (PubMed Central) · Cited by 33
Evidence for differential effects of apoE3 and apoE4 on HDL metabolism
Hopkins, P. C. R., Huang, Y., McGuire, J. G., & Pitas, R. E. (2002) · Journal of Lipid Research · doi:10.1194/jlr.m200172-jlr200 · Cited by 31
Jansen, D., Zerbi, V., Janssen, C. I. F., van Rooij, D., Zinnhardt, B., Dederen, P. J. W. C., Wright, A. J., Broersen, L. M., Lütjohann, D., Heerschap, A., et al. (2013) · Brain Structure and Function · doi:10.1007/s00429-013-0606-7 · Cited by 35
Biomimetic nano drug delivery carriers for treating cardiovascular diseases
Zinger, A., Cooke, J. P., & Taraballi, F. (2021) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2021.102360 · Cited by 32
Nakagawa, K., Tanaka, M., Hahm, T., Nguyen, H.-N., Matsui, T., Chen, Y.-X., & Nakashima, Y. (2021) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.121.316154 · Cited by 32
Self-citationMcLaren, J. E., Michael, D. R., Guschina, I. A., Harwood, J. L., & Ramji, D. P. (2011) · Lipids · doi:10.1007/s11745-011-3598-1 · Cited by 36
Cyclooxygenase products and atherosclerosis
Linton, M. F., & Fazio, S. (2008) · Drug Discovery Today Therapeutic Strategies · doi:10.1016/j.ddstr.2008.05.006 · Cited by 32
Aging Induces Endothelial Dysfunction While Sparing Arterial Thrombosis
Stämpfli, S. F., Akhmedov, A. T., Gebhard, C., Lohmann, C., Holy, E. W., Rozenberg, I., Spescha, R. D., Shi, Y., Lüscher, T. F., Tanner, F. C., et al. (2010) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.110.206920 · Cited by 32
Metadata
- Authors
- Nakashima, Y., Plump, A. S., Raines, E. W., Breslow, J. L., & Ross, R.
- Affiliations
- University of Washington (US)
- Venue
- Arteriosclerosis and Thrombosis: A Journal of Vascular Biology
- Published
- 1994-01
- Volume
- 14
- Issue
- 1
- Pages
- 133-140
- ISSN
- 1049-8834 (ISSN-L)
- OpenAlex
- W1964814612
- Cited by
- 1,693
- References
- 28
- Citations by year
- 2026: 18 · 2025: 32 · 2024: 40 · 2023: 42 · 2022: 54 · 2021: 60 · 2020: 47 · 2019: 57 · 2018: 45 · 2017: 66 · 2016: 50 · 2015: 69 · 2014: 71 · 2013: 73 · 2012: 78
- FWCI
- 14.99
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Arteriosclerosis and Thrombosis A Journal of Vascular Biology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Bristol-Myers Squibb
- National Institutes of Health (5r01hl033714-17, 18645, HL 18645)
- National Heart, Lung, and Blood Institute (HL-18645, HL 33714, R01HL032435, HL32435, P01HL018645)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Keywords
- apolipoprotein E deficiency, atherosclerosis, atherosclerotic plaque development, Western diet, hypercholesterolemia, fibrous cap, necrotic core, aortic root lesions, mouse model of atherosclerosis, atherogenesis
- MeSH terms
- Animals, Aorta, Aorta, Thoracic, Apolipoproteins E, Arteriosclerosis, Carotid Arteries, Coronary Vessels, Diet, Endothelium, Vascular, Hypercholesterolemia, Leukocytes, Mononuclear, Mice, Inbred BALB C, Mice, Inbred C57BL, Mice, Transgenic, Microscopy, Electron, Pulmonary Artery, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review